Corporate Banner
Satellite Banner
Technology Networks Header
Monday, October 20, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

£1.2m Investment Round for Videregen
Thursday, September 25, 2014
Significant £1.2m investment round for Videregen, led by SPARK Impact, to fund clinical trial of trachea replacement technology.

How Common Mutation in Asians Affects Heart Health
Thursday, September 25, 2014
Researchers studied heart muscle cells derived from pluripotent stem cells to find out why a genetic mutation common in East Asians leads to an increased risk of heart disease.

How Gene Expression Affects Facial Expressions
Tuesday, September 23, 2014
Researchers from USC have demonstrated how a mutation in TBX1 causes facial deformities associated with DiGeorge Syndrome.

Adaptimmune Named as One of “Fierce 15” Biotech Companies of 2014
Tuesday, September 23, 2014
Company has created T-cell receptors which are deployed to target NY-ESO-1.

Merck to Acquire Sigma-Aldrich
Monday, September 22, 2014
Merck to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx. $17 billion. Acquisition expands Merck Millipore’s global reach, increasing the company’s presence in North America and adding exposure to fast-growing Asian markets.

Stem Cells Use “First Aid Kits” to Repair Damage
Saturday, September 20, 2014
Neural stem cells - master cells that can develop into any type of nerve cell - are able to generate mini “first aid kits” and transfer them to immune cells, according to a study published.

Reliable and Highly Efficient Method for Making Stem Cells
Saturday, September 20, 2014
New finding could accelerate research to regenerate damaged tissue.

A New Molecule Allows for an Increase in Stem Cell Transplants
Saturday, September 20, 2014
A clinical study using UM171 and a new type of bioreactor developed for stem culture will be initiated in December 2014.

Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Friday, September 19, 2014
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 2178
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv